Antibody Engineering & Therapeutics US is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

James Broderick, M.D.
CEO and Founder at Palleon Pharmaceuticals

Profile

Jim Broderick is an accomplished biotech executive with more than 20 years of experience in the industry. He was Co-Founder and Chairman of Ra Pharmaceuticals (Nasdaq: RARX), founding CEO of SetPoint Medical, and Co-Founder and Chairman of Promedior, while he was a partner at the venture capital firm Morgenthaler Ventures. Jim founded Palleon in collaboration with the venture capital firm SR One, where he served as an Entrepreneur-in-Residence. He earned a Bachelor of Science degree in mechanical engineering from MIT and an MD from UMass Medical School.

James Broderick, M.D.'s Network

Agenda Sessions

  • Antibody-Enzyme Fusions to Target Siglec Glycans for Rx Effect in Cancer

    ,